Mariner’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Sell
24,922
-445
-2% -$39K ﹤0.01% 1485
2025
Q4
$2.15M Sell
25,367
-1,069
-4% -$85.3K ﹤0.01% 1453
2025
Q3
$1.92M Sell
26,436
-33
-0.1% -$2.28K ﹤0.01% 1469
2025
Q2
$1.73M Sell
26,469
-813
-3% -$52.9K ﹤0.01% 1439
2025
Q1
$1.93M Buy
27,282
+129
+0.5% +$8.96K ﹤0.01% 1271
2024
Q4
$1.78M Sell
27,153
-1,319
-5% -$90.8K ﹤0.01% 1280
2024
Q3
$2.01M Buy
28,472
+1,171
+4% +$81.6K ﹤0.01% 1183
2024
Q2
$1.81M Buy
27,301
+456
+2% +$29.9K ﹤0.01% 1162
2024
Q1
$1.82M Sell
26,845
-1,298
-5% -$85.8K ﹤0.01% 1160
2023
Q4
$1.74M Buy
28,143
+23,907
+564% +$1.41M ﹤0.01% 1119
2023
Q3
$250K Hold
4,236
﹤0.01% 2319
2023
Q2
$253K Hold
4,236
﹤0.01% 2259
2023
Q1
$247K Buy
4,236
+18
+0.4% +$1.08K ﹤0.01% 2227
2022
Q4
$262K Sell
4,218
-5,970
-59% -$359K ﹤0.01% 2137
2022
Q3
$576K Buy
+10,188
New +$628K ﹤0.01% 1336
2019
Q3
Sell
-4,068
Closed -$205K 850
2019
Q2
$205K Hold
4,068
﹤0.01% 1037
2019
Q1
$209K Buy
+4,068
New +$202K ﹤0.01% 955
2016
Q4
Sell
-138
Closed -$7K 677
2016
Q3
$7K Buy
+138
New +$7K ﹤0.01% 748

Other funds holding IHE

Mariner's IHE Position: Q1 2026 in Review

Mariner reduced its iShares US Pharmaceuticals ETF (IHE) stake by 1.8% in Q1 2026, selling an estimated $39K and leaving 24,922 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Mariner first reported a position in IHE in Q3 2016 and has held it in 18 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Mariner held 24,922 shares of iShares US Pharmaceuticals ETF worth $2.16M as of Q1 2026.
  • Mariner sold 445 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $39K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #1485 holding.
  • Mariner first reported a position in iShares US Pharmaceuticals ETF in Q3 2016 and has held it in 18 quarters since.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.